These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6796524)

  • 1. Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG.
    Hegardt B; Pauwels R; Van der Straeten M
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():283-5. PubMed ID: 6796524
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind evaluation of nebulized cromolyn, terbutaline, and the combination for childhood asthma.
    Shapiro GG; Furukawa CT; Pierson WE; Sharpe MJ; Menendez R; Bierman CW
    J Allergy Clin Immunol; 1988 Feb; 81(2):449-54. PubMed ID: 3123540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Pegelow KO; Strandberg K
    Allergy; 1980 Sep; 35(6):509-19. PubMed ID: 6110383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):113-21. PubMed ID: 6104452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulation of bronchial hyperreactivity.
    Lowhagen O
    Eur J Respir Dis Suppl; 1982; 117():97-120. PubMed ID: 6807704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway hyperreactivity. Clinical treatment with drugs.
    Svedmyr N
    Eur J Respir Dis Suppl; 1983; 131():313-29. PubMed ID: 6141065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotonic nebulized disodium cromoglycate provides better protection against methacholine- and exercise-induced bronchoconstriction.
    Weiner P; Saaid M; Reshef A
    Am Rev Respir Dis; 1988 Jun; 137(6):1309-11. PubMed ID: 3144199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma.
    Woolley M; Anderson SD; Quigley BM
    Chest; 1990 Jan; 97(1):39-45. PubMed ID: 2104792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of beta-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects.
    Larsson K; Martinsson A; Hjemdahl P
    Chest; 1992 Apr; 101(4):953-60. PubMed ID: 1313353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological rehabilitation of the asthmatic child.
    Debelić M
    Allergol Immunopathol (Madr); 1981; Suppl 9():99-102. PubMed ID: 6819777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-experimental possibilities in asthma].
    Debelic M
    Clin Ter; 1984 Feb; 108(4):273-82. PubMed ID: 6232063
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge II. Late response (LAR).
    Pelikan Z; Pelikan-Filipek M; Remeijer L
    Ann Allergy; 1988 Mar; 60(3):217-25. PubMed ID: 3126682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effects of nifedipine, DSCG and salbutamol in bronchospasm induced by ultrasonic mist].
    Mazzarella G; Cammarata A; Nardi S; Grella E
    Arch Monaldi Mal Torace; 1987; 42(2):183-90. PubMed ID: 3155409
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline.
    Finnerty JP; Howarth PH
    Am Rev Respir Dis; 1993 Aug; 148(2):512-3. PubMed ID: 8342917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen bronchial challenge and efficacy after 4 weeks of treatment with ketotifen and disodium cromoglycate.
    Palmen FM
    Respiration; 1983; 44(2):103-8. PubMed ID: 6403976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.